SMTL ID : 9gbq.1 (1 other biounit)

Human Angiotensin-1 converting enzyme N-domain in complex with a diprolyl inhibitor- SG15

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-FUC.1: 4 residues within 4Å: Chain A: N.416, E.522, P.524, Q.527 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:E.522 Hydrophobic interactions: A:P.524

2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 6 residues within 4Å: Chain A: N.45, T.47, E.49, N.50, R.53, R.326 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:T.47, A:N.50 Water bridges: A:N.45 NAG.9: 3 residues within 4Å: Chain A: N.480, T.482, H.483 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:T.482 Water bridges: A:E.161, A:N.480

1 x P33: 3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL(Non-covalent)

P33.3: 7 residues within 4Å: Chain A: Q.286, G.287, W.288, H.292, R.295, V.296 Ligands: PEG.5 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:H.292 Water bridges: A:R.295

3 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)

PEG.4: 3 residues within 4Å: Chain A: D.189, G.190, F.191 No protein-ligand interaction detected (PLIP) PEG.5: 5 residues within 4Å: Chain A: R.295, V.296, E.299, I.408 Ligands: P33.3 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:I.408 PEG.6: 6 residues within 4Å: Chain A: F.228, R.231, A.232, R.235, V.268, V.269 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:F.228, A:R.235 Water bridges: A:N.588

1 x ZN: ZINC ION(Non-covalent)

ZN.7: 4 residues within 4Å: Chain A: H.361, H.365, E.389 Ligands: 01.10 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.361, A:H.365, A:E.389

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.8: 6 residues within 4Å: Chain A: W.201, Y.202, P.385, P.497, I.499, R.500 Ligand excluded by PLIP

1 x 01: (2S)-1-[(2S)-2-[[(1S)-1-[(2S)-1-[(2S)-2-azanyl-3-phenyl-propanoyl]pyrrolidin-2-yl]-2-oxidanyl-2-oxidanylidene-ethyl]amino]propanoyl]pyrrolidine-2-carboxylic acid

01.10: 19 residues within 4Å: Chain A: Q.259, H.331, A.332, S.333, A.334, H.361, E.362, H.365, Y.369, H.388, E.389, K.489, F.490, H.491, T.496, Y.498, R.500, Y.501 Ligands: ZN.7 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:F.490, A:T.496, A:Y.501 Hydrogen bonds: A:Q.259, A:A.332, A:A.334, A:Y.369, A:Y.369, A:Y.498, A:Y.501 Water bridges: A:T.496 Salt bridges: A:H.331, A:H.361, A:H.365, A:K.489, A:H.491

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gregory, K.S. et al., Molecular basis of human angiotensin-1 converting enzyme inhibition by a series of diprolyl-derived compounds. Febs J. (2025)

Release Date

2025-01-22

Peptides

Angiotensin-converting enzyme, soluble form: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Angiotensin-converting enzyme, soluble form

Related Entries With Identical Sequence